Dolby Laboratories Inc. (DLB)
NYSE: DLB
· Real-Time Price · USD
68.76
-0.35 (-0.51%)
At close: Oct 15, 2025, 3:59 PM
69.20
0.64%
After-hours: Oct 15, 2025, 06:18 PM EDT
Dolby Laboratories Income Statement
Financials in USD. Fiscal
year is
October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
Period Ending | Sep 27, 2024 | Jun 30, 2023 | Sep 30, 2022 | Sep 24, 2021 |
Revenue | 1.27B | 1.01B | 1.25B | 1.28B |
Cost of Revenue | 140.5M | 117.01M | 141.36M | 130.03M |
Gross Profit | 1.13B | 892.17M | 1.11B | 1.15B |
Operating Income | 258.33M | 219.25M | 206.6M | 344.39M |
Interest Income | n/a | n/a | 6.57M | 3.49M |
Pretax Income | 312.48M | 241.02M | 215.28M | 354.51M |
Net Income | 360.64M | 191.47M | 184.09M | 310.23M |
Selling & General & Admin | 604.85M | 455.36M | 634.03M | 556.83M |
Research & Development | 263.66M | 201.1M | 261.17M | 253.64M |
Other Expenses | n/a | n/a | 2.5M | 7.11M |
Operating Expenses | 868.51M | 656.46M | 895.21M | 810.47M |
Interest Expense | 34.08M | n/a | 394K | 479K |
Selling & Marketing Expenses | 334.46M | 263.49M | 358.72M | 332.67M |
Cost & Expenses | 1.01B | 773.47M | 1.04B | 940.5M |
Income Tax Expense | -48.16M | -49.28M | 31.38M | 36.69M |
Shares Outstanding (Basic) | 95.54M | 95.79M | 99.99M | 101.19M |
Shares Outstanding (Diluted) | 97.33M | 97.59M | 101.98M | 104.62M |
EPS (Basic) | 3.77 | 2.00 | 1.84 | 3.07 |
EPS (Diluted) | 3.71 | 1.96 | 1.81 | 2.97 |
EBITDA | 258.33M | 219.25M | 329.9M | 464.12M |
EBIT | 312.48M | n/a | 206.6M | 344.39M |
Depreciation & Amortization | 87.33M | 71.26M | 123.3M | 119.73M |
Source: Financial Modeling Prep. Financial Sources.